However, anti-CCR7 therapy is not necessarily advantageous; for example, a study adapted a virus middle T-antigen (PyV MT) syngeneic adenocarcinoma mouse model to examine the effects of CCR7 expression on mammary tumor cell metastasis [33]. The gene discussed is CCR7; the disease is breast cancer.